Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D

Biochim Biophys Acta. 1996 Jul 18;1295(2):174-8. doi: 10.1016/0167-4838(96)00033-7.

Abstract

Factor J (FJ) is an inhibitor of the classical and alternative complement pathways. On the classical pathway factor J disrupts the C1 component, and on the alternative pathway, factor J disrupts the C3 convertase (C3b,Bb) by a direct interaction of FJ with the components C3b and Bb. The aim of this work was to verify whether FJ could have any effect on factor D proteolytic activity since previous experiments could not rule out an eventual inhibition by factor J on factor D enzymatic activity. For this purpose, the reactivity of serine proteinase factor D was determined by using two peptide thioester substrates, Z-Lys-SBzl.HCl and Z-Lys-Arg-SBzl.2HCl, in the presence and in the absence of factor J. Kinetic studies evidenced that FJ did not affect the enzymatic activity of factor D in any case.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complement C1 Inactivator Proteins / pharmacology*
  • Complement C3-C5 Convertases / antagonists & inhibitors
  • Complement Factor D / antagonists & inhibitors*
  • Complement Factor D / metabolism
  • Complement Pathway, Alternative / drug effects*
  • Complement Pathway, Classical / drug effects*
  • Enzyme Inhibitors / pharmacology
  • Esters / metabolism*
  • Humans
  • Hydrolysis
  • Kinetics

Substances

  • Complement C1 Inactivator Proteins
  • Enzyme Inhibitors
  • Esters
  • Complement C3-C5 Convertases
  • CFD protein, human
  • Complement Factor D